OAS1 gene, Spike protein variants and persistent COVID-19-related anosmia: may the olfactory disfunction be a harbinger of future neurodegenerative disease?

Eur Rev Med Pharmacol Sci. 2022 Jan;26(2):347-349. doi: 10.26355/eurrev_202201_27858.
No abstract available

MeSH terms

  • 2',5'-Oligoadenylate Synthetase / genetics*
  • Alleles
  • Alzheimer Disease / genetics
  • Alzheimer Disease / pathology
  • Anosmia / etiology*
  • COVID-19 / complications
  • COVID-19 / pathology*
  • COVID-19 / virology
  • Genome-Wide Association Study
  • Humans
  • Olfactory Bulb / metabolism
  • Polymorphism, Genetic
  • Prognosis
  • Risk Factors
  • SARS-CoV-2 / isolation & purification
  • SARS-CoV-2 / metabolism
  • Severity of Illness Index
  • Spike Glycoprotein, Coronavirus / genetics*

Substances

  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2
  • OAS1 protein, human
  • 2',5'-Oligoadenylate Synthetase